These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36639903)

  • 61. The Effect of Preventive Measures and Vaccination against SARS-CoV-2 on the Infection Risk, Treatment, and Hospitalization: A Cross-Sectional Study of Algeria.
    Hamimes A; Aouissi HA; Ababsa M; Lounis M; Jayarajah U; Napoli C; Kasemy ZA
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560775
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.
    Gamboa-Cárdenas RV; Barzola-Cerrón S; Toledo-Neira D; Reátegui-Sokolova C; Pimentel-Quiroz V; Zevallos-Miranda F; Alarcón GS; Ugarte-Gil M
    Clin Rheumatol; 2021 Nov; 40(11):4725-4734. PubMed ID: 34189675
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients.
    Douin DJ; Wogu AF; Beaty LE; Carlson NE; Bennett TD; Aggarwal NR; Mayer DA; Ong TC; Russell S; Steele J; Peers JL; Molina KC; Wynia MK; Ginde AA
    BMC Infect Dis; 2022 Nov; 22(1):818. PubMed ID: 36344927
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
    [TBL] [Abstract][Full Text] [Related]  

  • 65. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".
    Entrenas Castillo M; Entrenas Costa LM; Vaquero Barrios JM; Alcalá Díaz JF; López Miranda J; Bouillon R; Quesada Gomez JM
    J Steroid Biochem Mol Biol; 2020 Oct; 203():105751. PubMed ID: 32871238
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RE: Colchicine and risk of hospitalization due to COVID-19: A population-based study.
    Sáenz-Aldea M; Salgado-Barreira Á; Taracido-Trunk M; Piñeiro-Lamas M; Herdeiro MT; Portela-Romero M; Saez M; Figueiras A
    J Med Virol; 2023 Apr; 95(4):e28741. PubMed ID: 37185845
    [No Abstract]   [Full Text] [Related]  

  • 68. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors).
    Bonifácio LP; Ramacciotti E; Agati LB; Vilar FC; Silva ACTD; Louzada Júnior P; Fonseca BALD; Souza HCC; Oliveira CCC; Aguiar VCR; Quadros CAA; Dusilek C; Itinose K; Risson R; Ferreira LRR; Lopes RD; Kallas EG; Bellissimo-Rodrigues F
    Rev Soc Bras Med Trop; 2023; 56():e0565. PubMed ID: 37075454
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial.
    Klarskov CK; Lindegaard B; Pedersen-Bjergaard U; Kristensen PL
    Trials; 2020 Nov; 21(1):968. PubMed ID: 33239100
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prophylactic anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects.
    Al-Kuraishy HM; Al-Gareeb AI; Qusty N; Cruz-Martins N; El-Saber Batiha G
    Pulm Pharmacol Ther; 2021 Apr; 67():102008. PubMed ID: 33727066
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study.
    Evans A; Qi C; Adebayo JO; Underwood J; Coulson J; Bailey R; Lyons R; Edwards A; Cooper A; John G; Akbari A
    J Infect; 2023 Apr; 86(4):352-360. PubMed ID: 36773891
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Non-HIV-related comorbidities and uncontrolled HIV replication are independent factors increasing the odds of hospitalization due to COVID-19 among HIV-positive patients in Poland.
    Kowalska JD; Lara M; Hlebowicz M; Mularska E; Jabłonowska E; Siwak E; Wandałowicz A; Witak-Jędra M; Olczak A; Bociąga-Jasik M; Suchacz M; Stempkowska-Rejek J; Wasilewski P; Parczewski M
    Infection; 2023 Apr; 51(2):379-387. PubMed ID: 35882773
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.
    Golpour M; Mousavi T; Alimohammadi M; Mosayebian A; Shiran M; Alizadeh Navaei R; Rafiei A
    Int J Immunopathol Pharmacol; 2021; 35():20587384211031763. PubMed ID: 34250834
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial.
    Nickols NG; Goetz MB; Graber CJ; Bhattacharya D; Soo Hoo G; Might M; Goldstein DB; Wang X; Ramoni R; Myrie K; Tran S; Ghayouri L; Tsai S; Geelhoed M; Makarov D; Becker DJ; Tsay JC; Diamond M; George A; Al-Ajam M; Belligund P; Montgomery RB; Mostaghel EA; Sulpizio C; Mi Z; Dematt E; Tadalan J; Norman LE; Briones D; Clise CE; Taylor ZW; Huminik JR; Biswas K; Rettig MB
    Trials; 2021 Jul; 22(1):431. PubMed ID: 34225789
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
    Martins-Filho PR; Ferreira LC; Heimfarth L; Araújo AAS; Quintans-Júnior LJ
    Lancet Reg Health Am; 2021 Oct; 2():100062. PubMed ID: 34485970
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Racial/Ethnic Disparities in Post-acute Sequelae of SARS-CoV-2 Infection in New York: an EHR-Based Cohort Study from the RECOVER Program.
    Khullar D; Zhang Y; Zang C; Xu Z; Wang F; Weiner MG; Carton TW; Rothman RL; Block JP; Kaushal R
    J Gen Intern Med; 2023 Apr; 38(5):1127-1136. PubMed ID: 36795327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.